Trial Matching Validation: Early Insights from Real World Use

Session details:

This presentation shares early findings from Memorial Sloan Kettering Cancer Center’s validation of an AI‑enabled trial matching pilot. Following an initial study focused on two trials, MSKCC expanded the partnership based on demonstrated accuracy and feasibility. While a full outcomes analysis is still in progress, the session will highlights:

• How trial matching accuracy was initially assessed and validated

• Early indicators of effectiveness and operational limitations

• The resource and workflow burden associated with implementation

• Initial signals of ROI

• Practical lessons for organizations moving beyond pilot stage adoption